Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-03-24
DOI
10.3389/fphar.2020.00261
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglia Mediated Neuroinflammation: Focus on PI3K Modulation
- (2020) Antonia Cianciulli et al. Biomolecules
- Treatment Combinations for Alzheimer’s Disease: Current And Future Pharmacotherapy Options
- (2019) Jeffrey L. Cummings et al. JOURNAL OF ALZHEIMERS DISEASE
- Peripheral Demyelinating Diseases: From Biology to Translational Medicine
- (2019) Khidhir Kamil et al. Frontiers in Neurology
- Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: Pooled analysis from 5 cohorts
- (2019) Galit Weinstein et al. PLoS One
- Expression Changes of NMDA and AMPA Receptor Subunits in the Hippocampus in rats with Diabetes Induced by Streptozotocin Coupled with Memory Impairment
- (2019) Xiao-Peng Wang et al. NEUROCHEMICAL RESEARCH
- New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease
- (2019) Nicolas Sergeant et al. NEUROBIOLOGY OF DISEASE
- The amyloid cascade and Alzheimer’s disease therapeutics: theory versus observation
- (2019) Rudy J. Castellani et al. LABORATORY INVESTIGATION
- A pharmaceutical answer to nonadherence: Once weekly oral memantine for Alzheimer's disease
- (2019) Rosemary Kanasty et al. JOURNAL OF CONTROLLED RELEASE
- Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer’s Disease
- (2019) Yoshiyuki Soeda et al. JOURNAL OF ALZHEIMERS DISEASE
- Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer’s Disease
- (2019) Xin Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Methylene blue does not bypass Complex III antimycin block in mouse brain mitochondria
- (2019) Artem P. Gureev et al. FEBS LETTERS
- A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer’s Disease in Taiwan
- (2019) Chiung-Chih Chang et al. ADVANCES IN THERAPY
- High molecular weight amyloid β1-42 oligomers induce neurotoxicity via plasma membrane damage
- (2019) Taro Yasumoto et al. FASEB JOURNAL
- Lipoprotein‐associated phospholipase A2: The story continues
- (2019) Fubao Huang et al. MEDICINAL RESEARCH REVIEWS
- Alzheimer disease and aducanumab: adjusting our approach
- (2019) Dennis J. Selkoe Nature Reviews Neurology
- Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?
- (2019) Matthew J. Sharman et al. NEUROBIOLOGY OF DISEASE
- PKA-mediated phosphorylation of CREB and NMDA receptor 2B in the hippocampus of offspring rats is involved in transmission of mental disorders across a generation
- (2019) Yuejun Huang et al. PSYCHIATRY RESEARCH
- The Synthetic Retinoid Acitretin Increases IL-6 in the Central Nervous System of Alzheimer Disease Model Mice and Human Patients
- (2019) Malena dos Santos Guilherme et al. Frontiers in Aging Neuroscience
- Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease
- (2019) Lon S. Schneider et al. JAMA Neurology
- Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces Aβ levels in Alzheimer's disease models
- (2019) Zhan Zhang et al. AGING CELL
- Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease
- (2018) Hong-Yan Cai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise
- (2018) Christopher H. van Dyck BIOLOGICAL PSYCHIATRY
- Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo
- (2018) Sarah L DeVos et al. BRAIN
- Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice
- (2018) Zhenri Ou et al. BRAIN BEHAVIOR AND IMMUNITY
- Carvedilol protection against endogenous Aβ-induced neurotoxicity in N2a cells
- (2018) Jia Liu et al. CELL STRESS & CHAPERONES
- Spreading of Tau Pathology in Sporadic Alzheimer’s Disease Along Cortico-cortical Top-Down Connections
- (2018) Heiko Braak et al. CEREBRAL CORTEX
- Alcohol Addiction- Metabotropic Glutamate Receptor Subtype 5 and its Ligands: How They All Come Together?
- (2018) Jaya Kumar et al. CURRENT DRUG TARGETS
- A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia
- (2018) Ruth Knight et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease
- (2018) Manru Ren et al. EXPERIMENTAL NEUROLOGY
- Recent developments with tau-based drug discovery
- (2018) Khalid Iqbal et al. Expert Opinion on Drug Discovery
- Amyloid fibrils induce dysfunction of hippocampal glutamatergic silent synapses
- (2018) Bihua Bie et al. HIPPOCAMPUS
- Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus
- (2018) Qin Sun et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
- (2018) Jaume Folch et al. JOURNAL OF ALZHEIMERS DISEASE
- Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer’s Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study
- (2018) Stephen P. Salloway et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer’s Disease: Advances in Drug Development
- (2018) Morgane Piton et al. JOURNAL OF ALZHEIMERS DISEASE
- Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tauversusα-synuclein and β-amyloid aggregates
- (2018) Barbara E. Stopschinski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease
- (2018) Yinuo Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Microglia-targeted candidates push the Alzheimer drug envelope
- (2018) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- A new direction for Alzheimer's research
- (2018) JamesD Weinstein Neural Regeneration Research
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease
- (2018) Eduardo E. Benarroch NEUROLOGY
- MiR-134 modulates chronic stress-induced structural plasticity and depression-like behaviors via downregulation of Limk1/cofilin signaling in rats
- (2018) Cuiqin Fan et al. NEUROPHARMACOLOGY
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy
- (2018) Ghazaleh Kheiri et al. REVIEWS IN THE NEUROSCIENCES
- Setbacks in Alzheimer research demand new strategies, not surrender
- (2018) Björn Jobke et al. PLOS MEDICINE
- Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer's Disease
- (2018) Bushra Shal et al. Frontiers in Pharmacology
- Alzheimer’s Disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality
- (2018) Kevin Mullane et al. BIOCHEMICAL PHARMACOLOGY
- Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials
- (2018) Krzysztof Drygalski et al. EXPERIMENTAL GERONTOLOGY
- Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
- (2018) Teodoro del Ser et al. JOURNAL OF ALZHEIMERS DISEASE
- Identification of Polypeptides in Neurofibrillary Tangles and Total Homogenates of Brains with Alzheimer's Disease by Tandem Mass Spectrometry
- (2018) Benito Minjarez et al. JOURNAL OF ALZHEIMERS DISEASE
- AMPK Activation Ameliorates Alzheimer's Disease-Like Pathology and Spatial Memory Impairment in a Streptozotocin-Induced Alzheimer's Disease Model in Rats
- (2018) Lai-Ling Du et al. JOURNAL OF ALZHEIMERS DISEASE
- A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer’s Disease
- (2018) Sid E. O’Bryant et al. JOURNAL OF ALZHEIMERS DISEASE
- Microglia CREB-Phosphorylation Mediates Amyloid-β-Induced Neuronal Toxicity
- (2018) Yuan Gao et al. JOURNAL OF ALZHEIMERS DISEASE
- Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors
- (2018) Annachiara Gandini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
- (2018) Maarten Timmers et al. Alzheimers Research & Therapy
- Sleep Related Epilepsy and Pharmacotherapy: An Insight
- (2018) Jaya Kumar et al. Frontiers in Pharmacology
- The exploration of novel Alzheimer’s therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches
- (2018) Mubashir Hassan et al. BIOMEDICINE & PHARMACOTHERAPY
- Design, synthesis, cholinesterase inhibition and molecular modelling study of novel tacrine hybrids with carbohydrate derivatives
- (2018) João Paulo Bizarro Lopes et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Protective role of Dihydromyricetin in Alzheimer’s disease rat model associated with activating AMPK/SIRT1 signaling pathway
- (2018) Ping Sun et al. BIOSCIENCE REPORTS
- Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer’s disease
- (2018) Jangampalli Adi Pradeepkiran et al. DRUG DISCOVERY TODAY
- A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
- (2018) Justyna A Dobrowolska Zakaria et al. EMBO Molecular Medicine
- BACE inhibitors in clinical development for the treatment of Alzheimer’s disease
- (2018) Francesco Panza et al. Expert Review of Neurotherapeutics
- Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?
- (2018) Francesco Panza et al. Immunotherapy
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease
- (2018) Martin R. Farlow et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer’s Disease
- (2018) Ahmed Morsy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo
- (2018) Marc Aurel Busche et al. NATURE NEUROSCIENCE
- Olive and Its Phenolic Compound as the Promising Neuroprotective Agent
- (2018) Khidhir Kamil et al. Sains Malaysiana
- TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
- (2018) Honghua Zheng et al. Frontiers in Aging Neuroscience
- Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
- (2018) Nan Zhang et al. Clinical Interventions in Aging
- Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease
- (2018) Mikael Marttinen et al. Frontiers in Neuroscience
- A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease
- (2017) Bilqees Sameem et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Modulating 5-HT4 and 5-HT6 receptors in Alzheimer’s disease treatment
- (2017) Julien Lalut et al. Future Medicinal Chemistry
- Therapeutic effects of drug switching between acetylcholinesterase inhibitors in patients with Alzheimer's disease
- (2017) Yasuyuki Ohta et al. Geriatrics & Gerontology International
- Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer’s Disease
- (2017) Sachiko Nakayama et al. JOURNAL OF ALZHEIMERS DISEASE
- Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients
- (2017) Nzeera Ketter et al. JOURNAL OF ALZHEIMERS DISEASE
- Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases
- (2017) Valle Palomo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
- (2017) Charbel Moussa et al. Journal of Neuroinflammation
- Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease
- (2017) Kanchana K. Gamage et al. JOURNAL OF NEUROSCIENCE
- Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
- (2017) Sergey O. Bachurin et al. MEDICINAL RESEARCH REVIEWS
- Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
- (2017) Zhuohao He et al. NATURE MEDICINE
- Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model
- (2017) Virginie Vanden Dries et al. NEUROBIOLOGY OF AGING
- Edible Bird’s Nest Prevents Menopause-Related Memory and Cognitive Decline in Rats via Increased Hippocampal Sirtuin-1 Expression
- (2017) Zhiping Hou et al. Oxidative Medicine and Cellular Longevity
- Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases
- (2017) Romina Mancinelli et al. Oxidative Medicine and Cellular Longevity
- Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease
- (2017) Reisuke H. Takahashi et al. PATHOLOGY INTERNATIONAL
- Metabotropic glutamate receptors and neurodegenerative diseases
- (2017) Fabiola M. Ribeiro et al. PHARMACOLOGICAL RESEARCH
- RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
- (2017) Dimitry Ofengeim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A guanidine-appended scyllo-inositol derivative AAD-66 enhances brain delivery and ameliorates Alzheimer’s phenotypes
- (2017) Dohyun Lee et al. Scientific Reports
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- The Traditional Japanese Herbal Medicine Hachimijiogan Elicits Neurite Outgrowth Effects in PC12 Cells and Improves Cognitive in AD Model Rats via Phosphorylation of CREB
- (2017) Kaori Kubota et al. Frontiers in Pharmacology
- Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease
- (2016) Sung Min Son et al. Autophagy
- Resveratrol Improves Cognitive Impairment by Regulating Apoptosis and Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats
- (2016) Zhiyan Tian et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Drug treatments in Alzheimers disease
- (2016) R. Briggs et al. CLINICAL MEDICINE
- Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia
- (2016) James Cheng-Chung Wei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Functional connectivity increase in the default-mode network of patients with Alzheimer׳s disease after long-term treatment with Galantamine
- (2016) Janusch Blautzik et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
- (2016) William James Deardorff et al. Expert Review of Neurotherapeutics
- PI3k/Akt signalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia
- (2016) Antonia Cianciulli et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- PT596. The comparison with galantamine and donepezil on Alzheimer’s Disease patients and its relationship with cerebral blood flow
- (2016) INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
- (2016) Gvido Cebers et al. JOURNAL OF ALZHEIMERS DISEASE
- AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
- (2016) Susanna Eketjäll et al. JOURNAL OF ALZHEIMERS DISEASE
- Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
- (2016) José A. Luchsinger et al. JOURNAL OF ALZHEIMERS DISEASE
- Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease
- (2016) Florence Pasquier et al. JOURNAL OF ALZHEIMERS DISEASE
- The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination
- (2016) F. Luo et al. JOURNAL OF NEUROSCIENCE
- Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
- (2016) Taylor R. Jay et al. JOURNAL OF NEUROSCIENCE
- Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
- (2016) Serge Gauthier et al. LANCET
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer’s Disease
- (2016) Juan Jose Ramos-Rodriguez et al. MOLECULAR NEUROBIOLOGY
- Reduced pCREB in Alzheimer’s disease prefrontal cortex is reflected in peripheral blood mononuclear cells
- (2016) N Bartolotti et al. MOLECULAR PSYCHIATRY
- Attack on amyloid-β protein
- (2016) Eric M. Reiman NATURE
- The road to restoring neural circuits for the treatment of Alzheimer's disease
- (2016) Rebecca G. Canter et al. NATURE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
- (2016) William James Deardorff et al. Drug Design Development and Therapy
- A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy
- (2016) Philip Wong et al. Oncotarget
- BMS-708163 and Nilotinib restore synaptic dysfunction in human embryonic stem cell-derived Alzheimer’s disease models
- (2016) Hisae Nishioka et al. Scientific Reports
- Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
- (2016) Jeffrey L. Cummings et al. Alzheimers Research & Therapy
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
- (2016) Fernando Pagan et al. Journal of Parkinsons Disease
- Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
- (2016) William James Deardorff et al. Expert Review of Neurotherapeutics
- Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance
- (2015) J.-H. Lee et al. ACTA NEUROLOGICA SCANDINAVICA
- Masitinib for the treatment of mild to moderate Alzheimer’s disease
- (2015) Jaume Folch et al. Expert Review of Neurotherapeutics
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Tau in physiology and pathology
- (2015) Yipeng Wang et al. NATURE REVIEWS NEUROSCIENCE
- A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
- (2015) R. Scott Turner et al. NEUROLOGY
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease
- (2015) Mizuki Oka et al. Psychogeriatrics
- Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled A , tau, and -synuclein
- (2015) M. Goedert SCIENCE
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Masitinib for the treatment of mild to moderate Alzheimer’s disease
- (2015) Jaume Folch et al. Expert Review of Neurotherapeutics
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease
- (2015) Mizuki Oka et al. Psychogeriatrics
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- Lessons from a Failed γ-Secretase Alzheimer Trial
- (2014) Bart De Strooper CELL
- Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings
- (2014) David B. Henley et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pharmacotherapy of Alzheimer’s disease: current and future trends
- (2014) Werner J Geldenhuys et al. Expert Review of Neurotherapeutics
- A Novel Blood-Brain Barrier Co-Culture System for Drug Targeting of Alzheimer’s Disease: Establishment by Using Acitretin as a Model Drug
- (2014) Christian Freese et al. PLoS One
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alzheimer's -Secretase (BACE1) Regulates the cAMP/PKA/CREB Pathway Independently of -Amyloid
- (2012) Y. Chen et al. JOURNAL OF NEUROSCIENCE
- Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology
- (2012) Timothy Revett et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- PET amyloid-beta imaging in preclinical Alzheimer's disease
- (2011) Andrei G. Vlassenko et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Resolving controversies on the path to Alzheimer's therapeutics
- (2011) Dennis J Selkoe NATURE MEDICINE
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
- (2010) Harald Hampel et al. NATURE REVIEWS DRUG DISCOVERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started